1
|
Dragostin I, Dragostin OM, Samal SK, Dash S, Tatia R, Dragan M, Confederat L, Ghiciuc CM, Diculencu D, Lupușoru CE, Zamfir CL. New isoniazid derivatives with improved pharmaco-toxicological profile: Obtaining, characterization and biological evaluation. Eur J Pharm Sci 2019; 137:104974. [PMID: 31252051 DOI: 10.1016/j.ejps.2019.104974] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2018] [Revised: 06/10/2019] [Accepted: 06/25/2019] [Indexed: 02/07/2023]
Abstract
Tuberculostatic drugs are the most common drug groups with global hepatotoxicity. Awareness of potentially severe hepatotoxic reactions is vital, as hepatic impairment can be a devastating and often fatal condition. The treatment problems that may arise, within this class of medicines, are mainly of two types: adverse reactions (collateral, toxic or hypersensitive reactions) and the initial or acquired resistance of Mycobacterium tuberculosis to one or more antituberculosis drugs. Prevention of adverse reactions, increase treatment adherence and success rates, providing better control of tuberculosis (TB). In this regard, obtaining new drugs with low toxicity and high tuberculostatic potential is essential. Thus, in this work, we have designed or synthesized new derivatives of isoniazid (INH), such as new Isonicotinoylhydrazone (INH-a, INH-b and INH-c). These derivatives demonstrated good biocompatibility, antimicrobial property similar to that of parent isoniazid and last but not least, a significantly improved Pharmacotoxicological profile compared to that of isoniazid.
Collapse
Affiliation(s)
- Ionut Dragostin
- University of Medicine and Pharmacy Grigore T. Popa, Faculty of Medicine, Department of Histology, 16 Universitatii Str., 700115, Iasi, Romania
| | - Oana M Dragostin
- Dunarea de Jos University of Galati, Faculty of Medicine and Pharmacy, Research Centre in the Medical-Pharmaceutical Field, 47 Domneasca Str., Galati, Romania.
| | - Sangram Keshari Samal
- Laboratory of Biomaterials and Regenerative Medicine for Advanced Therapies, Materials Research Centre, Indian Institute of Science Bangalore, 560 012, Karnataka, India; Laboratory of Biomaterials and regenerative Medicine for Advanced Therapies, Indian Council of Medical Research-Regional Medical Research Centre, Bhubaneswar 751 023, Odisha, India
| | - Saumya Dash
- Laboratory of Biomaterials and Regenerative Medicine for Advanced Therapies, Materials Research Centre, Indian Institute of Science Bangalore, 560 012, Karnataka, India
| | - Rodica Tatia
- Romanian National Institute of Research and Development for Biological Sciences, 296 Splaiul Independentei, 060031 Bucharest, Romania
| | - Maria Dragan
- University of Medicine and Pharmacy Grigore T. Popa, Faculty of Pharmacy, 16 Universitatii Str., 700115, Iasi, Romania
| | - Luminița Confederat
- University of Medicine and Pharmacy Grigore T. Popa, Faculty of Medicine, Department of Microbiology, 16 Universitatii Str., 700115, Iasi, Romania
| | - Cristina M Ghiciuc
- University of Medicine and Pharmacy Grigore T. Popa, Faculty of Medicine, Department of Pharmacology, 16 Universitatii Str., 700115, Iasi, Romania
| | - Daniela Diculencu
- Clinical Pneumophysiology Hospital, Medical Analysis Laboratory, Iasi, Romania
| | - Cătălina E Lupușoru
- University of Medicine and Pharmacy Grigore T. Popa, Faculty of Medicine, Department of Pharmacology, 16 Universitatii Str., 700115, Iasi, Romania
| | - Carmen L Zamfir
- University of Medicine and Pharmacy Grigore T. Popa, Faculty of Medicine, Department of Histology, 16 Universitatii Str., 700115, Iasi, Romania
| |
Collapse
|